SB-334867 is an orexin antagonist. It was the first non-peptide antagonist developed that is selective for the orexin receptor subtype OX1, with around...
10 KB (996 words) - 21:32, 22 January 2024
antagonist SB-334867 – first non-peptide selective OX1 antagonist – has been shown to produce sedative and anorectic effects in animals SB-408124 – selective...
19 KB (1,978 words) - 11:32, 1 May 2024
Thompson LK, Hemrick-Luecke SK (November 2007). "The orexin-1 antagonist SB-334867 blocks antipsychotic treatment emergent catalepsy: implications for the...
14 KB (1,660 words) - 05:48, 23 June 2024
(INDV-2000) CR-5542 Daridorexant Filorexant GSK-649868 (SB-649868) JNJ-61393215 Lemborexant RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102 Vornorexant (ORN-0829...
21 KB (1,687 words) - 04:21, 27 January 2024
(INDV-2000) CR-5542 Daridorexant Filorexant GSK-649868 (SB-649868) JNJ-61393215 Lemborexant RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102 Vornorexant (ORN-0829...
48 KB (4,075 words) - 03:39, 13 May 2024
example, blocking the orexin-1 receptor with the selective orexin antagonist SB-334,867 reduced nicotine self-administration in rats and that smokers who...
54 KB (6,129 words) - 20:20, 27 June 2024
(INDV-2000) CR-5542 Daridorexant Filorexant GSK-649868 (SB-649868) JNJ-61393215 Lemborexant RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102 Vornorexant (ORN-0829...
5 KB (653 words) - 05:33, 8 December 2023
(INDV-2000) CR-5542 Daridorexant Filorexant GSK-649868 (SB-649868) JNJ-61393215 Lemborexant RTIOX-276 SB-334867 SB-408124 Suvorexant TCS-1102 Vornorexant (ORN-0829...
5 KB (301 words) - 11:39, 13 January 2024
doi:10.1002/ana.26641. PMC 10330114. PMID 36897120. S2CID 257444346. Schipper SB, Van Veen MM, Elders PJ, van Straten A, Van Der Werf YD, Knutson KL, et al...
94 KB (8,958 words) - 18:56, 5 July 2024
mass: 319.317 g/mol, exact mass: 319.1069 u) may refer to: Nitrazolam SB-334867 This set index page lists chemical structure articles associated with...
328 bytes (56 words) - 16:44, 15 March 2021